Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
675.04
482.38
401.86
365.98
353.87
306.49
251.25
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
675.04
482.38
401.86
365.98
353.87
306.49
251.25
Raw Material Cost
10.88
6.48
5.38
5.28
5.58
5.50
5.21
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
280.32
184.26
152.85
122.36
105.33
100.36
81.29
Other Expenses
24.69
18.44
13.10
11.39
11.48
8.90
7.52
Total Expenditure (Excl Depreciation)
538.09
375.09
289.22
241.50
225.67
194.88
161.75
Operating Profit (PBDIT) excl Other Income
137
107.30000000000001
112.6
124.5
128.2
111.6
89.5
Other Income
24.54
17.27
3.56
0.53
3.40
5.07
2.66
Operating Profit (PBDIT)
162.83
125.60
119.16
128.07
133.84
118.85
92.39
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
664.16
475.89
396.47
360.70
348.29
300.98
246.03
Depreciation
1.34
1.04
2.97
3.07
2.24
2.17
0.24
Profit Before Tax
161.49
124.56
116.19
125.01
131.60
116.68
92.15
Tax
20.28
18.42
14.77
12.49
25.59
22.50
16.74
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
139.73
105.50
101.29
112.51
106.01
94.18
75.41
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
139.73
105.50
101.29
112.51
106.01
94.18
75.41
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
139.73
105.50
101.29
112.51
106.01
94.18
75.41
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
679.59
506.70
501.84
375.81
523.34
371.18
275.88
Earnings per share (EPS)
1.23
0.94
0.87
0.89
0.85
0.77
0.6
Diluted Earnings per share
1.23
0.94
0.87
0.89
0.85
0.77
0.6
Operating Profit Margin (Excl OI)
20.29%
22.24%
28.03%
34.01%
36.23%
36.41%
35.62%
Gross Profit Margin
24.12%
26.04%
29.65%
34.99%
37.82%
38.78%
36.77%
PAT Margin
20.7%
21.87%
25.2%
30.74%
29.96%
30.73%
30.01%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 39.93% vs 20.03% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 32.42% vs 4.15% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 27.70% vs -6.31% in Dec 2023
Interest
No Interest in the last few periods
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has fallen from Dec 2023
Compare Annual Results Of Corcept Therapeutics, Inc. With
Figures in Million
Consolidate Annual Results
Change(USD)
Change(%)
Net Sales
675.04
1,137.76
-462.72
-40.67%
Other Operating Income
0.00
0.00
0.00
Total Operating income
675.04
1,137.76
-462.72
-40.67%
Raw Material Cost
10.88
524.59
-513.71
-97.93%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
47.63
-47.63
-100.00%
Selling and Distribution Expenses
280.32
263.93
16.39
6.21%
Other Expenses
24.69
-4.76
29.45
618.70%
Total Expenditure (Excl Depreciation)
538.09
788.52
-250.43
-31.76%
Operating Profit (PBDIT) excl Other Income
136.95
349.24
-212.29
-60.79%
Other Income
24.54
-4.95
29.49
595.76%
Operating Profit (PBDIT)
162.83
374.46
-211.63
-56.52%
Interest
0.00
47.63
-47.63
-100.00%
Exceptional Items
0.00
-12.47
12.47
100.00%
Gross Profit (PBDT)
664.16
613.17
50.99
8.32%
Depreciation
1.34
30.17
-28.83
-95.56%
Profit Before Tax
161.49
284.19
-122.70
-43.18%
Tax
20.28
69.58
-49.30
-70.85%
Provisions and contingencies
0
0
0.00
Profit After Tax
139.73
214.60
-74.87
-34.89%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
139.73
214.60
-74.87
-34.89%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
139.73
214.60
-74.87
-34.89%
Equity Capital
0
0
0.00
Face Value
0.00
0.01
0.00
Reserves
679.59
1,834.90
-1,155.31
-62.96%
Earnings per share (EPS)
1.23
4.29
-3.06
-71.33%
Diluted Earnings per share
1.23
4.29
-3.06
-71.33%
Operating Profit Margin (Excl OI)
20.29%
30.70%
0.00
-10.41%
Gross Profit Margin
24.12%
27.63%
0.00
-3.51%
PAT Margin
20.70%
18.86%
0.00
1.84%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 67.50 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 39.93% vs 20.03% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 13.97 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 32.42% vs 4.15% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 13.83 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 27.70% vs -6.31% in Dec 2023
Annual - Interest
No Interest in the last few periods
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 20.29%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has fallen from Dec 2023
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
